Investing.com -- Sensei Biotherapeutics (NASDAQ:SNSE) stock soared 200% Wednesday after the company announced its acquisition of Faeth Therapeutics and a concurrent $200 million private placement. The ...

Acquisition of Faeth and concurrent $200 million private investment positions the combined company to advance its pipeline across key clinical milestones in endometrial and breast cancer PIKTOR is an ...

The Opener is The FADER’s short-form profile series of casual conversations with exciting new artists. Compton rapper-singer Wallie The Sensei has a voice like silk thanks to his childhood years ...

Sensei Biotherapeutics Inc. (NASDAQ: SNSE) jumped 62.88% to $17.20 in after-hours trading on Thursday. On Thursday, Cambrian BioPharma Inc., a 10% shareholder, submitted two Form 144 filings with the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Sensei Biotherapeutics is down ...

After already halving its workforce twice since 2022, Sensei Therapeutics is forging ahead with another deep round of cuts. The biotech on Friday said 65% of its staffers are set to leave the company.

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its options. Two weeks ago, the biotech reported phase 1/2 data for its ...

BOSTON - Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) announced Thursday it will discontinue development of its cancer drug solnerstotug and initiate a strategic review to maximize shareholder value.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Lockhart officials are heralding ...

One of the world’s richest men is expanding his investments in Central Texas. Sensei Farms, the agriculture company backed by Oracle Corp. co-founder, Chairman and Chief Technology Officer Larry ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...